Diffusion-weighted magnetic resonance imaging of head and neck

Journal of Computer Assisted Tomography

Volumn 34, Issue 6, 2010, Pages 808-815

  Razek, Ahmed Abdel Khalek Abdel ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

diffusion; head; MR imaging; neck

Indexed keywords

DIAGNOSIS; DIFFUSION; GRADING; MAGNETISM; RESONANCE; SITE SELECTION; TUMORS;

CLINICAL APPLICATION; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; HEAD; HEAD AND NECK; HEAD-AND-NECK TUMOR; LYMPHADENOPATHY; MR IMAGING; NECK; RECURRENT TUMORS; SQUAMOUS CELL CARCINOMA;

MAGNETIC RESONANCE IMAGING;

CANCER CLASSIFICATION; CANCER GRADING; CLINICAL EFFECTIVENESS; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; ELECTRON SPIN RESONANCE; HEAD AND NECK CANCER; IMAGING SYSTEM; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; TUMOR RECURRENCE;

EID: 78650486510     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181f01796     Document Type: Review

References (40)

1. Hermans R, Vandecaveye V. Diffusion-weighted MRI in head and neck cancer. Cancer Imaging. 2007;7:126-127. (Pubitemid 47570281)
2. Maeda M, Maier S. Usefulness of diffusion-weighted imaging and the apparent diffusion coefficient in the assessment of head and neck tumors. J Neuroradiol. 2008;35:71-78.
3. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: Characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621-630.
4. Vandecaveye V, De Keyzer F, Hermans R. Diffusion-weighted magnetic resonance imaging in neck lymphadenopathy. Cancer Imaging. 2008;8:173-180.
5. Friedrich K, Matzek W, Gentzsch S, et al. Diffusion-weighted magnetic resonance imaging of head and neck squamous cell carcinomas. Eur J Radiol. 2008;68:493-498.
6. Thoeny H, Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol. 2007;17:1385-1393.
7. Koh D, Collins D. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol. 2007;88:1622-1635.
8. Sakamoto J, Yoshino N, Okochi K, et al. Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE. Eur J Radiol. 2009;69:260-268.
9. Srinivasan A, Dvorak R, Perni K, et al. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: Early experience. AJNR Am J Neuroradiol. 2008; 29:40-44.
10. Abdel Razek A, Gaballa G, Elhawarey G, et al. Characterization of pediatric head and neck masses with diffusion weighted MR imaging. Eur Radiol. 2009;19:201-208.
11. Habermann C, Arndt C, Graessner J, et al. Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: Is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol. 2009;30:591-596.
12. Yerli H, Agildere AM, Aydi E, et al. Value of apparent diffusion coefficient calculation in the differential diagnosis of parotid gland tumors. Acta Radiol. 2007;48:980-987.
13. Eida S, Sumi M, Sakihama N, et al. Apparent diffusion coefficient mapping of salivary gland tumors: Prediction of the benignancy and malignancy. AJNR Am J Neuroradiol. 2007;28:116-121.
14. Abdel Razek AK, Sadek A, Ombar O, et al. Role of apparent diffusion coefficient value in differentiation between malignant and benign solitary thyroid nodule. AJNR Am J Neuroradiol. 2008;29: 563-568.
15. Bozgeyik Z, Coskun S, Dagli AF, et al. Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology. 2009;51:193-198.
16. Schueller-Weidekamm C, Kaserer K, Schueller G, et al. Can quantitative diffusion-weighted MR imaging differentiate benign and malignant cold thyroid nodules? Initial results in 25 patients. AJNR Am J Neuroradiol. 2009;30:417-422.
17. White ML, Zhang Y, Robinson RA. Evaluating tumors and tumorlike lesions of the nasal cavity, the paranasal sinuses, and the adjacent skull base with diffusion-weighted MRI. J Comput Assist Tomogr. 2006; 30:490-495.
18. Abdel Razek A, Samir S, Bilal M. Assessment of nasal and paranasal sinus masses with diffusion weighted echoplanar MR imaging. J Neuroradiol. 2009;36:206-211.
19. Maeda M, Kato H, Sakuma H, et al. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol. 2005;26:1186-1192.
20. Sumi M, Ichikawa Y, Nakamura T. Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol. 2007;17:2631-2637.
21. Abdel Razek A, Megahed A, Motamed A, et al. Role of diffusion weighted MR imaging in differentiation between viable and necrotic part of head and neck tumors. Acta Radiol. 2008;49:364-370.
22. Abdel Razek A, Soliman N, Elkhammary S, et al. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16:1468-1477.
23. King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: Diagnostic accuracy of diffusion-weighted MR imaging. Radiology. 2007;245:806-813.
24. Vandecaveye V, De Keyzer F, Poorten V, et al. Head and neck squamous cell carcinoma: Value of diffusion-weighted MR imaging for nodal staging. Radiology. 2009;251:134-146.
25. Sumi M, Nakamura T. Diagnostic importance of focal defects in the apparent diffusion coefficientYbased differentiation between lymphoma and squamous cell carcinoma nodes in the neck. Eur Radiol. 2009; 19:975-981.
26. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2007;67: 960-971.
27. Abdel Razek A, Kandeel A, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol. 2007;28:1146-1152.
28. Kato H, Kanematsu M, Tanaka O. Head and neck squamous cell carcinoma: Usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol. 2009;19: 103-109.
29. Galbán C, Mukherji S, Chenevert T, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Translational Oncology. 2009;2:184-190.
30. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
31. Dirix P, De Keyzer F, Vandecaveye V, et al. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71: 1365-1371.
32. Sumi M, Ichikawa Y, Katayama I, et al. Imaging of ameloblastomas and keratocystic odontogenic tumors: Differentiation by apparent diffusion coefficients of cystic lesions. AJNR Am J Neuroradiol. 2008;29:1897-1901.
33. Suzuki C, Maeda M, Matsumine A, et al. Apparent diffusion coefficient of subcutaneous epidermal cysts in the head and neck comparison with intracranial epidermoid cysts. Acad Radiol. 2007; 14:1020-1028.
34. Kapur R, Sepahdari A, Mafee M, et al. MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: The role of diffusion-weighted imaging. AJNR Am J Neuroradiol. 2009;30:64-70.
35. Soares-Fernandes J, Valle-Folgueral J, Morais N, et al. Diffusion-weighted MR imaging findings in an isolated abscess of the clivus. AJNR Am J Neuroradiol. 2008;29:51-52.
36. Tezuka M, Murata Y, Ishida R, et al. MR imaging of the thyroid: Correlation between apparent diffusion coefficient and thyroid gland scintigraphy. J Magn Reson Imaging. 2003;17:163-169.
37. Kawai Y, Sumi M, Kitamori H, et al. Diffusion-weighted MR microimaging of the lacrimal glands in patients with Sjögren's syndrome. AJR Am J Roentgenol. 2005;184:1320-1325.
38. Regier M, Ries T, Arndt C, et al. Sjögren's syndrome of the parotid gland: Value of diffusion-weighted echo-planar MRI for diagnosis at an early stage based on MR sialography grading in comparison with healthy volunteers. Rofo. 2009;181:242-248.
39. Hickman SJ, Wheeler-Kingshott CA, Jones SJ, et al. Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. AJNR AmJ Neuroradiol. 2005;26:951-956.
40. Al-Shafai LS, Mikulis DJ. Diffusion MR imaging in a case of acute ischemic optic neuropathy. AJNR Am J Neuroradiol. 2006;27: 255-257.